


Elusys Therapeutics Email Formats
Biotechnology Research • Parsippany, New Jersey, United States • 21-50 Employees
Elusys Therapeutics Email Formats
Elusys Therapeutics uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@elusys.com), used 84.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@elusys.com | 84.6% |
{first name}{last name} | johndoe@elusys.com | 15.4% |
Key Contacts at Elusys Therapeutics
Evan Brower
Director, Cmc
Jennifer White
Associate Director Quality Assurance
David Taylor
Associate Director - Analytical
Christa Nagy
Director Clinical Operations
Cynthia Dillon
Executive Director, Regulatory Affairs
Laura Kaufman
Director, Nonclinical Studies
Company overview
| Headquarters | 2001 Route 46, Suite 310, Parsippany, New Jersey 07054, US |
| Phone number | +18448080222 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Keywords | Biodefense, Anthrax, Anthim, Nyxthracis, Obiltoxaximab |
| Founded | 1998 |
| Employees | 21-50 |
| Socials |
About Elusys Therapeutics
Elusys Therapeutics is dedicated to delivering innovative medical countermeasures that enable fast, effective, and durable protection against infectious agents. Our goal is to accelerate the development and commercialization of novel biodefense solutions, such as our anthrax antitoxin ANTHIM® (obiltoxaximab), for strategic government partners.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Elusys Therapeutics has 10 employees across 5 departments.
Departments
Number of employees
Funding Data
Elusys Therapeutics has never raised funding before.
Elusys Therapeutics Tech Stack
Discover the technologies and tools that power Elusys Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Web servers
Security
JavaScript libraries
JavaScript libraries
Programming languages
Miscellaneous
Blogs
Page builders
Miscellaneous
JavaScript libraries
Databases
Miscellaneous
Frequently asked questions
4.8
40,000 users



